Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-01-26

Clinical Trial Update: NAVISTAR® THERMOCOOL® SF Catheter: Observational Study

View source ↗

Summary

Observational study of the NAVISTAR ThermoCool SF Catheter in atrial fibrillation and paroxysmal arrhythmias has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NAVISTAR ThermoCool SF Catheter

Snippet

Sponsor: Biosense Webster, Inc. | Conditions: Atrial Fibrillation, Paroxysmal Arrhythmia | Status: COMPLETED | Results posted: 2015-01-26